Myelodysplastic syndromes - Coping with ineffective hematopoiesis

New England Journal of Medicine

Volumn 352, Issue 6, 2005, Pages 536-538

  Cazzola, Mario ^a,b   Malcovati, Luca ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZACITIDINE; CYCLOSPORIN A; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; LENALIDOMIDE; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC STEM CELL TRANSPLANTATION; ANEMIA; BLOOD SMEAR; BONE MARROW DISEASE; CLINICAL FEATURE; CLONAL VARIATION; COPING BEHAVIOR; DISEASE CLASSIFICATION; DISEASE COURSE; ERYTHROCYTE TRANSFUSION; GENETIC PREDISPOSITION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HISTOPATHOLOGY; HUMAN; IRON CHELATION; MYELODYSPLASTIC SYNDROME; NEUTROPENIA; PRIORITY JOURNAL; PROGNOSIS; SHORT SURVEY; SURVIVAL RATE; SYMPTOMATOLOGY; THROMBOCYTOPENIA;

ANGIOGENESIS INHIBITORS; HEMATOPOIESIS; HUMANS; MYELODYSPLASTIC SYNDROMES; THALIDOMIDE;

EID: 13444269356     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMp048266     Document Type: Short Survey

References (5)

1. Song WJ, Sullivan MG, Legare RD, et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat Genet 1999;23:166-75.
2. Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002;100:2292-302.
3. Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997;89:2079-88. [Erratum, Blood 1998;91:1100.]
4. Alessandrino EP, Amadori S, Barosi G, et al. Evidence- and consensus-based practice guidelines for the therapy of primary myelodysplastic syndromes: a statement from the Italian Society of Hematology. Haematologica 2002;87:1286-306.
5. Cools J, DeAngelo DJ, Gotlib J, et al. A tyrosine kinase created by fusion of the PDGFRA and FIPIL1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 2003;348:1201-14.